DE3583765D1 - Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen. - Google Patents

Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
DE3583765D1
DE3583765D1 DE8585810100T DE3583765T DE3583765D1 DE 3583765 D1 DE3583765 D1 DE 3583765D1 DE 8585810100 T DE8585810100 T DE 8585810100T DE 3583765 T DE3583765 T DE 3583765T DE 3583765 D1 DE3583765 D1 DE 3583765D1
Authority
DE
Germany
Prior art keywords
hydanto
derivatives
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585810100T
Other languages
English (en)
Inventor
C O Nippon Zoki Pharm C Ienaga
C O Nippon Zoki Pharm Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Zoki Pharmaceutical Co Ltd
Original Assignee
Nippon Zoki Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP59045278A external-priority patent/JPH062748B2/ja
Priority claimed from JP59241439A external-priority patent/JPH0686436B2/ja
Application filed by Nippon Zoki Pharmaceutical Co Ltd filed Critical Nippon Zoki Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3583765D1 publication Critical patent/DE3583765D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
DE8585810100T 1984-03-08 1985-03-08 Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen. Expired - Fee Related DE3583765D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59045278A JPH062748B2 (ja) 1984-03-08 1984-03-08 新規ヒダントイン誘導体及び該化合物を有効成分として含有する医薬組成物
JP59241439A JPH0686436B2 (ja) 1984-11-15 1984-11-15 新規ヒダントイン誘導体及び該化合物を含有する医薬組成物

Publications (1)

Publication Number Publication Date
DE3583765D1 true DE3583765D1 (de) 1991-09-19

Family

ID=26385246

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585810100T Expired - Fee Related DE3583765D1 (de) 1984-03-08 1985-03-08 Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.

Country Status (6)

Country Link
US (1) US4647574A (de)
EP (1) EP0160618B1 (de)
KR (1) KR930001835B1 (de)
AU (1) AU578068B2 (de)
DE (1) DE3583765D1 (de)
ES (1) ES8609272A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2678499B2 (ja) * 1989-08-09 1997-11-17 日本臓器製薬 株式会社 尿毒症毒素低下剤
US5681843A (en) * 1994-12-20 1997-10-28 Nippon Zoki Pharmaceutical Co., Ltd. Parabanic acid derivatives
US5912261A (en) * 1994-12-20 1999-06-15 Nippon Zoki Pharmaceutical Co., Ltd. Carboxyalkyl heterocyclic derivatives
US6197806B1 (en) 1995-12-20 2001-03-06 Nippon Zoki Pharmaceutical Co., Ltd. Eliminating agent for activated oxygen and free radicals
JPH10182460A (ja) * 1996-12-27 1998-07-07 Nippon Zoki Pharmaceut Co Ltd ３−デオキシグルコソン生成阻害剤
KR19980076014A (ko) * 1997-04-04 1998-11-16 성재갑 용액상 및 고체상 반응을 이용한 하이덴토인 유도체의 합성방법
AU754989B2 (en) 1998-11-16 2002-11-28 Nippon Zoki Pharmaceutical Co., Ltd. A therapeutic agent for intractable vasculitis
DE19934231B4 (de) * 1999-07-21 2004-02-19 Bayer Ag Verfahren zur Herstellung von 1-substituierten 5-Hydroxy-imidazolin-2,4-dionen und 1-substituierten 5-Alkoxy-imidazolin-2,4-dionen
JP4711523B2 (ja) * 2001-02-13 2011-06-29 日本臓器製薬株式会社 低アルブミン血症改善剤
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
US20060241162A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (R)-hydantoin derivative
US20060241163A1 (en) * 2005-04-20 2006-10-26 Kaoru Okamoto Optically active (S)-hydantoin derivative
US11090313B2 (en) 2010-05-20 2021-08-17 University Of Iowa Research Foundation Methods for inhibiting muscle atrophy
AU2011255495A1 (en) 2010-05-20 2012-12-06 The United States Of America, As Represented By The Secretary Of The Department Of Veterans Affairs Methods for inhibiting muscle atrophy
JP6001060B2 (ja) 2011-06-06 2016-10-05 ユニバーシティ オブ アイオワ リサーチ ファウンデーション 筋萎縮を阻害するための方法
CN117100744B (zh) * 2023-10-11 2024-04-02 吉林大学 1-mh在制备减肥、降血脂、治疗脂肪肝和糖尿病的药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2553055A (en) * 1946-11-07 1951-05-15 Dow Chemical Co Synthesis of 5-(sec.-butyl) hydantion
NL292187A (de) * 1962-05-02
US3395153A (en) * 1964-12-16 1968-07-30 United States Borax Chem 3, 5-dialkylhydantoins
CH523278A (de) * 1968-11-11 1972-05-31 Ciba Geigy Ag Verfahren zur Herstellung von neuen Diglycidyläthern von N-heterocyclischen Verbindungen und deren Verwendung
US3696198A (en) * 1970-04-02 1972-10-03 Frederick J Mccarty Treatment of anoxia with 3,5-dialkyl hydantoins
US3847933A (en) * 1970-12-09 1974-11-12 Exxon Research Engineering Co Acid catalyzed alkylation of hydantoin
NL158172B (nl) * 1972-09-18 1978-10-16 Farmaceutici Italia Werkwijze voor het bereiden van tetracyclinederivaten met een substituent op de 7-plaats.
IE46672B1 (en) * 1977-03-18 1983-08-24 Kanegafuchi Chemical Ind Process for preparing 5-(4-hydroxyphenyl)hydantoin
GB1600880A (en) * 1978-05-23 1981-10-21 Lilly Industries Ltd Pharmaceutical compositions comprising hydantoin derivatives
US4198423A (en) * 1979-03-20 1980-04-15 Basf Aktiengesellschaft 1,3-Bis-(trihalomethylsulfenyl)-imidazoline-2,4-diones

Also Published As

Publication number Publication date
ES8609272A1 (es) 1986-07-16
EP0160618A1 (de) 1985-11-06
US4647574A (en) 1987-03-03
ES541029A0 (es) 1986-07-16
KR850006187A (ko) 1985-10-02
KR930001835B1 (ko) 1993-03-15
AU578068B2 (en) 1988-10-13
AU3917285A (en) 1985-09-12
EP0160618B1 (de) 1991-08-14

Similar Documents

Publication Publication Date Title
DE69014351T2 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
DE3486441D1 (de) 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen
IT1232677B (it) Composizione farmaceutica contenente ranitidina
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
FI893643A0 (fi) Farmaceutiska kompositioner.
DE3579730D1 (de) Eisen-3-hydroxypyron- oder 3-hydroxypyridon-komplexe und diese enthaltende pharmazeutische zusammensetzungen.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
DE68909501T2 (de) Hydroxyalkylcystein-Derivate und diese enthaltende Expectoranzien.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
IT1213453B (it) Composizione farmaceutica.
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DE68909555D1 (de) Pyridylketoximether-verbindung und diese enthaltende pharmazeutische zusammensetzung.
DE68907609D1 (de) Arzneimittelzusammensetzung.
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
DE3671630D1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
DE68902056D1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
KR900700471A (ko) 신규의 2,3-티오모르폴린디온-2-옥심유도체, 이들을 함유하는 약제학적 조성물 및 제법
ATE66213T1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
DE3667915D1 (de) Pharmazeutische zusammensetzung.
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
ATE50995T1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee